2013-02-05 12:58:24 -

ORION CORPORATION STOCK EXCHANGE RELEASE 5 FEBRUARY 2013 at 1.50 PM  EET

The Board of Directors of Orion Corporation has decided on a new share-based
incentive plan for the Group key persons. The aim of the Plan is to combine the
objectives of the shareholders and the key persons in order to increase the
value of the Company, to commit the key persons to the Company, and to offer
them a competitive reward plan based on holding the Company's shares.

The Plan includes earning periods. The Board of Directors decides annually on
the beginning and duration of the earning periods in 2013, 2014 and 2015. The
Board of Directors  decides on the earnings criteria and on targets to be
established for them at the beginning of each earning period. Two earning
periods, calendar   year 2013 and calendar years 2013-2015, commenced upon
implementation of the Plan. The potential reward of the Plan, for the earning
period 2013, is based on the Orion Group's operating profit and, for the earning
period 2013-2015, on the total return on Orion Corporation class B share.

The potential reward will be paid partly as the Company's class B shares and
partly in cash in 2014, on the basis of the earning period 2013, and in 2016 on
the basis of the earning period 2013-2015. The proportion to be paid in cash
will be used for taxes and tax-related costs arising from the reward to a key
person. The value of reward to be paid on the basis of the Plan and the Orion
Share-based incentive plan established in 2010 during one calendar year is a key
person's gross annual salary multiplied by 1.75, in the maximum, at the date of
the reward payment. Gross annual salary means total salary together with fringe
benefits, excluding annual bonus and long-term incentive plan. The shares paid
on the basis of the earning period 2013 cannot be transferred during the
restriction period, which will end on 31 December 2015 with the exception that
notwithstanding the transfer restrictions relating to the shares to be paid on
the basis of the Plan, a person belonging to the Plan may purchase Orion
Corporation A shares at will and at his/her expense on the stock exchange or
otherwise and enter these shares under the transfer restriction of the Plan, and
after the acquisition transfer a corresponding number of B shares under the
transfer restriction.
The target group of the Plan consists of approximately 35 people. The total
maximum amount of rewards to be paid on the basis of the Plan is 500,000 Orion
Corporation class B shares and a cash payment corresponding to the value of the
shares.


Orion Corporation


 Timo Lappalainen  Olli Huotari
 President and CEO SVP, Corporate Functions

Contact person:
Olli Huotari, SVP, Corporate Functions, tel. +358 10 426 3054, mobile
+358 50 966 3054

Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo
www.orion.fi


Orion is a globally operating Finnish company developing pharmaceuticals and
diagnostic tests - a builder of well-being. Orion develops, manufactures and
markets human and veterinary pharmaceuticals, active pharmaceutical ingredients
and diagnostic tests. The company is continuously developing new drugs and
treatment methods. Pharmaceutical R&D focuses on central nervous system drugs,
oncology and critical care drugs, and Easyhaler(®) pulmonary drugs.

Orion's net sales in 2012 amounted to EUR 980 million and the company had about
3,500 employees. Orion's A and B shares are listed on NASDAQ OMX Helsinki.





This announcement is distributed by Thomson Reuters on behalf of 
Thomson Reuters clients. The owner of this announcement warrants that: 
(i) the releases contained herein are protected by copyright and 
    other applicable laws; and 
(ii) they are solely responsible for the content, accuracy and 
     originality of the information contained therein. 
    
Source: Orion Oyj via Thomson Reuters ONE
[HUG#1675566]